Abstract
In the last twenty years, the use of Arabidopsis as a model plant sped up discoveries at the molecular levels in different plant-parasite interactions. Nowadays, we know of probably hundreds of genes that are involved in the one or the other defence reaction, offering hundreds of targets for drug development. Even more interesting, identifying crucial regulatory components might allow to influence the various defence pathways as needed. Moreover, since some pathogenic strategies are conserved between animal and plant pathogens, results obtained with one system might be applicable to the other.
Keywords: Arabidopsis thaliana, bacteria, fungi, insect, nematode, oomycete, pathogen defence signalling, phytopathogens, virus
Current Drug Targets
Title: Arabidopsis thaliana- The Model Plant to Study Host-Pathogen Interactions
Volume: 12 Issue: 7
Author(s): Nikolaus L. Schlaich
Affiliation:
Keywords: Arabidopsis thaliana, bacteria, fungi, insect, nematode, oomycete, pathogen defence signalling, phytopathogens, virus
Abstract: In the last twenty years, the use of Arabidopsis as a model plant sped up discoveries at the molecular levels in different plant-parasite interactions. Nowadays, we know of probably hundreds of genes that are involved in the one or the other defence reaction, offering hundreds of targets for drug development. Even more interesting, identifying crucial regulatory components might allow to influence the various defence pathways as needed. Moreover, since some pathogenic strategies are conserved between animal and plant pathogens, results obtained with one system might be applicable to the other.
Export Options
About this article
Cite this article as:
L. Schlaich Nikolaus, Arabidopsis thaliana- The Model Plant to Study Host-Pathogen Interactions, Current Drug Targets 2011; 12 (7) . https://dx.doi.org/10.2174/138945011795677863
DOI https://dx.doi.org/10.2174/138945011795677863 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Immunotherapy of B-Cell Malignancy Using CD19-Targeted CAR T-Cells
Current Gene Therapy Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era
Reviews on Recent Clinical Trials VIP in Inflammatory Bowel Disease: State of the Art
Endocrine, Metabolic & Immune Disorders - Drug Targets Contribution of NRF2 in Gastrointestinal Protection from Oxidative Injury
Current Pharmaceutical Design Disruption of Circadian Rhythms and Sleep in Critical Illness and its Impact on Innate Immunity
Current Pharmaceutical Design Rutin as a Natural Therapy for Alzheimer's Disease: Insights into its Mechanisms of Action
Current Medicinal Chemistry From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
Current Neuropharmacology Role of Pharmacogenomics in Antiepileptic Drug Therapy: Current Status and Future Perspectives
Current Pharmaceutical Design Novel Therapeutic Targets for Phosphodiesterase 5 Inhibitors: current state-of-the-art on systemic arterial hypertension and atherosclerosis
Current Pharmaceutical Biotechnology Hyaluronic Acid/Parecoxib-Loaded PLGA Microspheres for Therapy of Temporomandibular Disorders
Current Drug Delivery Drug Discovery and Target Identification against Schistosomiasis: A Reality Check on Progress and Future Prospects
Current Topics in Medicinal Chemistry The beneficial effect of Cape gooseberry juice on carbon tetrachloride-induced neuronal damage
CNS & Neurological Disorders - Drug Targets Discovery, Development and Design of Anthocyanins-Inspired Anticancer Agents: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry Contrast Enhanced Sonography for Diagnosis of (Peri-) Splenic Pathology
Current Medical Imaging HIV-1 Proteins, Tat and gp120, Target the Developing Dopamine System
Current HIV Research Subject Index Volume 2
Medicinal Chemistry Respiration and Energy Homeostasis
Current Respiratory Medicine Reviews Gamma-Secretase as a Pharmacological Target in Alzheimer Disease Research: When, Why and How?
Current Pharmaceutical Design Reflections on MicroRNAs in Chronic Pulmonary Disease: Looking into the miR-ror and Crystal Ball
Inflammation & Allergy - Drug Targets (Discontinued) The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies
Current Molecular Medicine